Use of repaglinide on a pregnant woman during embryogenesis

Diabetes, Obesity and Metabolism

Volumn 9, Issue 1, 2007, Pages 146-147

  Mollar Puchades, M A ^a   Martin Cortes, A ^a   Perez Calvo, A ^a   Diaz Garcia, C ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Embryogenesis; Oral antihyperglycaemic agents; Pregnancy; Repaglinide

Indexed keywords

HEMOGLOBIN A1C; INSULIN; REPAGLINIDE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DELIVERY; DRUG EFFICACY; DRUG SUBSTITUTION; EMBRYO DEVELOPMENT; FEMALE; FIRST TRIMESTER PREGNANCY; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HUMAN; MATERNAL DIABETES MELLITUS; MULTIPLE CYCLE TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PRENATAL DRUG EXPOSURE;

EID: 33845537971     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2006.00629.x     Document Type: Article

References (5)

1. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000; 343: 1134-1138.
2. Wilton LV, Pearce GL, Martin RM, Mackay FJ, Mann RD. The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol 1998; 105: 882-889.
3. Hawthorne G. Metformin use and diabetic pregnancy - has its time come? Diabet Med 2006; 23: 223-227.
4. Viertel B, Guttner J. Effects of the oral antidiabetic repaglinide on the reproduction of rats. Arzneimittelforschung 2000; 50: 425-440.
5. Briggs GG. Drugs, pregnancy and lactation: Oral antidiabetic agents. Ob Gyn News 2004; 39: 12.